PFG Advisors Sells 70,774 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

PFG Advisors trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 77.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,063 shares of the exchange traded fund’s stock after selling 70,774 shares during the quarter. PFG Advisors’ holdings in SPDR S&P Biotech ETF were worth $1,807,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $141,284,000. Proficio Capital Partners LLC increased its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares during the last quarter. Mirae Asset Securities USA Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $55,529,000.

SPDR S&P Biotech ETF Trading Up 1.1 %

Shares of XBI stock opened at $87.15 on Thursday. The stock’s 50-day moving average price is $90.28 and its 200-day moving average price is $95.02. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.